Medical devices in pediatrics is an underserved area due to the characteristics of the patient. Children are usually less likely to be sick, the regulatory and ethical complexity treating children and lastly, the changing nature of growing children’s bodies creating its own challenges.
Support for pediatric medical technology innovators commenced under Consortium for Technology & Innovation in Pediatrics (known as CTIP), has been through the PDC program funded by the US FDA in 2009. To date there have been 4 cycles of the program.
The goal of the program is to support innovators and experts in pediatrics to develop safe, effective medical devices designed specifically for pediatric patients.
Patient outcomes have a strong focus in pediatrics and adult medicine is playing catchup.
Dr Juan Espinoza as the Director and Chief Investigator at the West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) spoke with Mike Lesner in Global Health Talks.
-
Clinical research and trials in Australia and New Zealand
Clinical research and trials in the Australia and New Zealand region offer foreign companies an opportunity to collaborate with local institutions, tap into diverse patient populations, access high-quality healthcare infrastructure, and gain regulatory approvals, enabling them to expand their market reach and accelerate the development of innovative medical interventions.
Clinical trials continued in Australia and New Zealand during lockdown, thanks to collaboration between industry and government, allowing the region to attract trials from other countries.
-
Global effort to reduce postoperative infection risk
Infection rates following surgical procedure vary across countries, however the causes and the ranges of variation are not well understood.
The causes of the infections are not as high as would be assumed on the surgical procedure, but co-morbidity and lifestyle choices including alcohol consumption may exacerbate risk. As Dr Edmiston states, there are a myriad of causes, and funding is limited in many countries. However there are some solutions, where goals, performance tracking against the goals and better communication is needed.
-
Australia’s digital health push into new national markets
Infection rates following surgical procedure vary across countries, however the causes and the ranges of variation are not well understood.
The causes of the infections are not as high as would be assumed on the surgical procedure, but co-morbidity and lifestyle choices including alcohol consumption may exacerbate risk. As Dr Edmiston states, there are a myriad of causes, and funding is limited in many countries. However there are some solutions, where goals, performance tracking against the goals and better communication is needed.
